Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Haude

Showing results (121-130 of 208) with videos related to

Pageof 21
Sort By:
Cardiology|March 10, 2021
Management of Pulmonary Embolism: Results from the German Chest Pain Unit RegistryStephan Settelmeier, Matthias Hochadel, Evangelos Giannitsis, et al.
Circulation. Cardiovascular Interventions|November 21, 2013
Serial observation of drug-eluting absorbable metal scaffold: multi-imaging modality assessmentRon Waksman, Francesco Prati, Nico Bruining, et al.
JACC. Advances|July 4, 2025
Changes in Coronary Physiology by μFR Measurement After DREAMS-3G-Scaffold ImplantationHector M Garcia-Garcia, Ryan L Wallace, Adrian Wlodarczak, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 26, 2020
Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stentsPhilipp Nicol, Anna Bulin, Maria Isabel Castellanos, et al.
JACC. Cardiovascular Interventions|October 21, 2019
Safety and Performance Outcomes of a Self-Expanding Transcatheter Aortic Heart Valve: The BIOVALVE TrialsUlrich Schäfer, Jörg Kempfert, Stefan Verheye, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 17, 2009
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)Stefan Verheye, Giovanna Sarno, Ralf Müller, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 27, 2019
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trialMichael Haude, Hüseyin Ince, Ralph Toelg, et al.
Circulation|May 1, 2004
Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolizationAndreas Skyschally, Michael Haude, Hilmar Dörge, et al.
Circulation|March 12, 2003
Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patientsMichael Haude, Thomas F M Konorza, Uldis Kalnins, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 12, 2020
Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 YearsMichael Haude, Hüseyin Ince, Stephan Kische, et al.
Pageof 21

Showing results (121-130 of 208) with videos related to

Sort By:
Pageof 21
Cardiology|March 10, 2021
Management of Pulmonary Embolism: Results from the German Chest Pain Unit RegistryStephan Settelmeier, Matthias Hochadel, Evangelos Giannitsis, et al.
Circulation. Cardiovascular Interventions|November 21, 2013
Serial observation of drug-eluting absorbable metal scaffold: multi-imaging modality assessmentRon Waksman, Francesco Prati, Nico Bruining, et al.
JACC. Advances|July 4, 2025
Changes in Coronary Physiology by μFR Measurement After DREAMS-3G-Scaffold ImplantationHector M Garcia-Garcia, Ryan L Wallace, Adrian Wlodarczak, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 26, 2020
Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stentsPhilipp Nicol, Anna Bulin, Maria Isabel Castellanos, et al.
JACC. Cardiovascular Interventions|October 21, 2019
Safety and Performance Outcomes of a Self-Expanding Transcatheter Aortic Heart Valve: The BIOVALVE TrialsUlrich Schäfer, Jörg Kempfert, Stefan Verheye, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 17, 2009
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)Stefan Verheye, Giovanna Sarno, Ralf Müller, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 27, 2019
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trialMichael Haude, Hüseyin Ince, Ralph Toelg, et al.
Circulation|May 1, 2004
Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolizationAndreas Skyschally, Michael Haude, Hilmar Dörge, et al.
Circulation|March 12, 2003
Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patientsMichael Haude, Thomas F M Konorza, Uldis Kalnins, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 12, 2020
Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 YearsMichael Haude, Hüseyin Ince, Stephan Kische, et al.
Pageof 21